Equillium Stock Price Prediction

EQ Stock  USD 1.55  0.01  0.64%   
As of today, the RSI of Equillium's share price is approaching 44 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Equillium, making its price go up or down.

Oversold Vs Overbought


Equillium stock price prediction is an act of determining the future value of Equillium shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Equillium's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Equillium and does not consider all of the tangible or intangible factors available from Equillium's fundamental data. We analyze noise-free headlines and recent hype associated with Equillium, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Equillium's stock price prediction:
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Equillium based on different types of headlines from major news networks to social media. The Equillium stock price prediction module provides an analysis of price elasticity to changes in media outlook on Equillium over a specific investment horizon. Using Equillium hype-based prediction, you can estimate the value of Equillium from the perspective of Equillium response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Equillium using Equillium's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Equillium using crowd psychology based on the activity and movement of Equillium's stock price.

Equillium Implied Volatility

Equillium's implied volatility exposes the market's sentiment of Equillium stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Equillium's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Equillium stock will not fluctuate a lot when Equillium's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Equillium. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Equillium to buy its stock at a price that has no basis in reality. In that case, they are not buying Equillium because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Equillium after-hype prediction price

  USD 1.55  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Equillium Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Equillium's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
4 Analysts
Estimates (0)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Equillium. Your research has to be compared to or analyzed against Equillium's peers to derive any actionable benefits. When done correctly, Equillium's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Equillium.

Equillium After-Hype Price Prediction Density Analysis

As far as predicting the price of Equillium at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Equillium or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Equillium, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Equillium Estimiated After-Hype Price Volatility

In the context of predicting Equillium's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Equillium's historical news coverage. Equillium's after-hype downside and upside margins for the prediction period are 0.08 and 8.13, respectively. We have considered Equillium's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
After-hype Price
Equillium is extremely dangerous at this time. Analysis and calculation of next after-hype price of Equillium is based on 3 months time horizon.

Equillium Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Equillium is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Equillium backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Equillium, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
10 Events / Month
15 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Equillium Hype Timeline

As of May 21, 2024 Equillium is listed for 1.55. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.02. Equillium is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.56%. %. The volatility of related hype on Equillium is about 17406.9%, with the expected price after the next announcement by competition of 1.53. About 36.0% of the company shares are held by company insiders. The book value of Equillium was currently reported as 0.6. The company recorded a loss per share of 0.35. Equillium had not issued any dividends in recent years. Allowing for the 90-day total investment horizon the next projected press release will be in about 10 days.
Check out Equillium Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.

Equillium Related Hype Analysis

Having access to credible news sources related to Equillium's direct competition is more important than ever and may enhance your ability to predict Equillium's future price movements. Getting to know how Equillium's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Equillium may potentially react to the hype associated with one of its peers.
At Risk
LYRALyra TherapeuticsInc 0.22 9 per month 0.00 (0.18) 6.85 (11.81) 96.46 
HOOKHookipa Pharma 0.03 9 per month 3.18  0.09  9.88 (5.81) 24.40 
LIANLianBio ADR 0.04 7 per month 0.00  0.13  7.63 (2.84) 12,487 
JSPRJasper Therapeutics(0.63)10 per month 4.47  0.1  8.01 (7.42) 20.69 
CINGWCingulate Warrants 0.00 0 per month 20.90  0.17  62.45 (45.00) 386.94 
SABSSAB Biotherapeutics(0.70)6 per month 0.00 (0.15) 6.01 (8.86) 27.62 
ANEBAnebulo Pharmaceuticals 0.00 5 per month 0.00 (0.05) 6.20 (6.36) 31.09 
CVKDCadrenal Therapeutics Common 0.02 8 per month 0.00 (0.20) 5.26 (10.77) 31.27 
MNPRMonopar Therapeutics 0.02 9 per month 6.47  0.11  16.07 (10.37) 114.41 
SPROSpero Therapeutics 0.01 10 per month 2.87  0.02  4.82 (4.60) 16.04 
BOLTBolt Biotherapeutics(0.02)6 per month 0.00 (0.06) 7.14 (5.84) 51.88 
CHRSCoherus BioSciences 0.09 9 per month 0.00 (0.10) 5.70 (7.34) 20.74 
GRCLGracell Biotechnologies 0.01 9 per month 2.36  0.16  8.38 (3.42) 61.23 
NLTXNeoleukin Therapeutics(0.12)2 per month 0.00 (0.04) 6.67 (5.67) 15.97 
IKNAIkena Oncology 0.04 8 per month 3.09  0.04  7.63 (5.26) 23.04 
HOWLWerewolf Therapeutics(0.03)9 per month 0.00 (0.06) 9.37 (9.12) 31.06 
EWTXEdgewise Therapeutics 0.46 10 per month 3.52  0.01  5.44 (5.89) 17.83 
QNRXQuoin Pharmaceuticals Ltd 0.05 8 per month 0.00 (0.25) 5.36 (8.46) 53.64 
KTTAPasithea Therapeutics Corp 0.00 3 per month 3.29  0.01  8.94 (6.56) 21.06 
LIFEaTyr Pharma 0.02 9 per month 3.13  0.01  4.79 (6.01) 28.85 
TRVITrevi Therapeutics(0.02)9 per month 3.79  0.09  9.45 (6.69) 23.67 
CUECue Biopharma(0.11)10 per month 0.00 (0.03) 11.32 (8.57) 46.19 
ANTXAN2 Therapeutics(0.36)8 per month 0.00 (0.20) 4.07 (8.67) 25.27 
BCABBioatlaInc 0.11 9 per month 6.35  0.02  14.95 (12.40) 57.82 

Equillium Additional Predictive Modules

Most predictive techniques to examine Equillium price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Equillium using various technical indicators. When you analyze Equillium charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Equillium Predictive Indicators

The successful prediction of Equillium stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Equillium, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Equillium based on analysis of Equillium hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Equillium's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Equillium's related companies.
 2021 2022 2023 2024 (projected)
Current Ratio9.42.411.791.7
Net Debt To EBITDA1.073.061.561.29

Story Coverage note for Equillium

The number of cover stories for Equillium depends on current market conditions and Equillium's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Equillium is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Equillium's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Equillium Short Properties

Equillium's future price predictability will typically decrease when Equillium's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Equillium often depends not only on the future outlook of the potential Equillium's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Equillium's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding34.7 M
Cash And Short Term Investments40.9 M
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Equillium Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.